Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Donati

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Scandinavian Journal of Immunology|May 11, 2005
Circulating epstein-barr virus in children living in malaria-endemic areasN Rasti, K I Falk, D Donati, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.
Journal of Medicinal Chemistry|March 14, 1997
Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding siteR Di Fabio, A M Capelli, N Conti, et al.
Transplantation Proceedings|June 21, 2005
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing TrialE Gotti, N Perico, F Gaspari, et al.
Transplantation Proceedings|April 26, 2005
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporineG Montagnino, S Sandrini, C Casciani, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonistsA Ursini, A M Capelli, R A Carr, et al.
Cancer Treatment Reviews|November 19, 2021
SELNET clinical practice guidelines for soft tissue sarcoma and GISTJ Y Blay, N Hindi, J Bollard, et al.
Cancer Treatment Reviews|February 16, 2023
Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312]J Y Blay, N Hindi, J Bollard, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Scandinavian Journal of Immunology|May 11, 2005
Circulating epstein-barr virus in children living in malaria-endemic areasN Rasti, K I Falk, D Donati, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.
Journal of Medicinal Chemistry|March 14, 1997
Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding siteR Di Fabio, A M Capelli, N Conti, et al.
Transplantation Proceedings|June 21, 2005
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing TrialE Gotti, N Perico, F Gaspari, et al.
Transplantation Proceedings|April 26, 2005
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporineG Montagnino, S Sandrini, C Casciani, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonistsA Ursini, A M Capelli, R A Carr, et al.
Cancer Treatment Reviews|November 19, 2021
SELNET clinical practice guidelines for soft tissue sarcoma and GISTJ Y Blay, N Hindi, J Bollard, et al.
Cancer Treatment Reviews|February 16, 2023
Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312]J Y Blay, N Hindi, J Bollard, et al.
Pageof 22